Uptake of the human papillomavirus (HPV) vaccine has been "very low to moderate," but it is having a substantial impact in reducing one of HPV's most common symptoms among young women, adolescent girls, and some young men, the CDC reports.
Uptake of the human papillomavirus (HPV) vaccine has been "very low to moderate," but it is having a substantial impact in reducing one of HPV's most common symptoms among young women, adolescent girls, and some young men, the CDC reports.